- Trials with a EudraCT protocol (608)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
608 result(s) found for: Human Immunodeficiency Virus.
Displaying page 1 of 31.
EudraCT Number: 2011-004435-31 | Sponsor Protocol Number: MVC116278 | Start Date*: 2012-05-15 | |||||||||||
Sponsor Name:ViiV Healthcare UK Limited | |||||||||||||
Full Title: An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc. | |||||||||||||
Medical condition: HIV-1 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) IT (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000240-94 | Sponsor Protocol Number: CLEAR0001 | Start Date*: 2012-05-09 | ||||||||||||||||
Sponsor Name:Aarhus University Hospital | ||||||||||||||||||
Full Title: The Safety and Efficacy of The Histone Deacetylase Inhibitor Panobinostat for Purging HIV-1 from The Latent Reservoir (CLEAR) Study | ||||||||||||||||||
Medical condition: Human Immunodeficiency Virus (HIV) Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-008556-16 | Sponsor Protocol Number: PRADA | Start Date*: 2009-07-13 | |||||||||||
Sponsor Name:Radboud University Nijmegen Medical Centre | |||||||||||||
Full Title: Pharmacokinetic and safety study of RAltegravir and atazanavir in a once DAily dose regimen in HIV-1 in-fected patients (PRADA) | |||||||||||||
Medical condition: HIV infected patients | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000390-59 | Sponsor Protocol Number: P03802 | Start Date*: 2004-07-15 | |||||||||||
Sponsor Name:SCHERING-PLOUGH | |||||||||||||
Full Title: Safety and efficacy of SCH 417690 in HIV-infected treatment-naive subjects | |||||||||||||
Medical condition: HIV-1 infected naive subject | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003463-31 | Sponsor Protocol Number: P04999 | Start Date*: 2010-08-23 | ||||||||||||||||
Sponsor Name:Schering-Plough Research Institute | ||||||||||||||||||
Full Title: COVER- Registro de observación continua tras exposición Vicriviroc (VCV) | ||||||||||||||||||
Medical condition: Síndrome de inmunodeficiencia adquirida (SIDA) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2022-001591-33 | Sponsor Protocol Number: DoRSwitch.21 | Start Date*: 2022-10-06 | |||||||||||
Sponsor Name:Fundació Clinic per a la Recerca Biomèdica | |||||||||||||
Full Title: Open-label, single-arm, unicenter and Pilot Study of a Switch strategy from Etravirine (ETR) to Doravirine (DOR) in Virologically-Suppressed HIV-1 Infected Adults With ETR-Resistance | |||||||||||||
Medical condition: Human Immunodeficiency Virus (HIV) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-007018-12 | Sponsor Protocol Number: QUINAVIR | Start Date*: 2008-06-23 | |||||||||||
Sponsor Name:Carlos Alonso-Villaverde Lozano, Hospital Universitari Sant Joan de Reus | |||||||||||||
Full Title: “Estudio prospectivo, abierto, aleatorizado y cruzado sobre el efecto de la Hidroxicloroquina, 200mg al día, en factores inflamatorios y metabólicos relacionados con la enfermedad cardiovascular en... | |||||||||||||
Medical condition: Infección por el virus de la inmunodeficiencia adquirida | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011273-32 | Sponsor Protocol Number: 149/09 | Start Date*: 2009-05-07 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Pilot study for the evaluation of the safety and the feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in patients on stable treatment with two NRTIs + atazanavir/ritonav... | |||||||||||||
Medical condition: HIV | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002978-35 | Sponsor Protocol Number: HLS05/2008 | Start Date*: 2008-07-24 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
Full Title: Intensification of HAART with Maraviroc (MVC) as first line therapy of HIV-1-infected patients to rapidly suppress viral replication and minimize the evolution of drug-resistant variants | |||||||||||||
Medical condition: First line therapy of HIV-1-infected patients. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005786-11 | Sponsor Protocol Number: GS-ES-164-0154 | Start Date*: 2006-03-28 | |||||||||||
Sponsor Name:Gilead Sciences S.L. | |||||||||||||
Full Title: Pilot phase IV, multicenter, randomized, open-label and controlled study to assess the evolution of peripheral body fat distribution after switching from AZT containing backbone to Truvada in HIV-1... | |||||||||||||
Medical condition: Human Immunodeficiency Virus (HIV-1) infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016480-11 | Sponsor Protocol Number: 2009HD/01 | Start Date*: 2009-12-28 | |||||||||||
Sponsor Name:P Pierre Dellamonica | |||||||||||||
Full Title: “No Nuc, No Boost” : A phase 2 pilot study of simplification by Maraviroc-Raltegravir following 6 months of treatment with Maraviroc-Raltegravir-Tenofovir-Emtricitabine in naive patients infected b... | |||||||||||||
Medical condition: HIV naïve patients, CCR5 tropism, with CD4 > 200/mm3 and HIV RNA < 100 000 copy/ml. | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006212-30 | Sponsor Protocol Number: IMIRC1002 | Start Date*: 2007-08-09 | |||||||||||
Sponsor Name:Imperial College London | |||||||||||||
Full Title: A Randomised, Open labelled, Phase II, Immunogenicity, and Exploratory Efficacy Evaluation of Therapeutic Immunisations +/- IL-2, GM-CSF and Growth Hormone in HIV-1 Infected Subjects Receiving High... | |||||||||||||
Medical condition: HIV-1 | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001058-26 | Sponsor Protocol Number: P04285 | Start Date*: 2006-01-09 | |||||||||||
Sponsor Name:Schering-Plough Research Institute | |||||||||||||
Full Title: Vicriviroc (SCH 417690) in Combination Treatment with Optimized ART Regimen in Experienced Subjects (VICTOR-E2) | |||||||||||||
Medical condition: HIV infection (mixed X4/R5 torpism) with previous therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) PT (Prematurely Ended) DE (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-013126-16 | Sponsor Protocol Number: TMC125-TiDP35-C239 | Start Date*: 2009-11-09 | |||||||||||
Sponsor Name:Tibotec Pharmaceuticals c/o Tibotec BVBA | |||||||||||||
Full Title: Continued access to etravirine in treatment experienced HIV-1 infected children and adolescents. | |||||||||||||
Medical condition: HIV-1 Infection | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Ongoing) ES (Ongoing) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001111-39 | Sponsor Protocol Number: UMCN-AKF13.03 | Start Date*: 2014-12-08 | ||||||||||||||||
Sponsor Name:Radboud University Nijmegen Medical Center | ||||||||||||||||||
Full Title: Once daily DArunavir/ritonavir in HIV-infected children 6-12 years old: a PHarmacokiNEtic validation of model-based dosing recommendations (DAPHNE) | ||||||||||||||||||
Medical condition: HIV infected children treated with darunavir | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-005192-14 | Sponsor Protocol Number: HLS03/2012 | Start Date*: 2013-01-31 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
Full Title: Strategic study of dual-therapy with darunavir/ritonavir and rilpivirine QD versus triple-therapy in patients with suppressed viral load: virological efficacy and evaluation of non-HIV related morb... | |||||||||||||
Medical condition: HIV infection. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004120-39 | Sponsor Protocol Number: A5271010 | Start Date*: 2006-02-08 | |||||||||||
Sponsor Name:Pfizer Pharma GmbH | |||||||||||||
Full Title: A randomised, double blind, placebo-controlled, multicentre study in asymptomatic HIV infected patients to investigate pharmacodynamics, pharmacokinetics, safety and toleration of UK-453,061 | |||||||||||||
Medical condition: HIV | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022202-41 | Sponsor Protocol Number: MRVstudy-10 | Start Date*: 2011-01-27 | |||||||||||
Sponsor Name:Daniel Podzamczer | |||||||||||||
Full Title: ESTUDIO PILOTO DEL CAMBIO EN LA ACTIVIDAD ANTIRRETROVIRAL EN SISTEMA NERVIOSO CENTRAL TRAS LA SUSTITUCIÓN DE TDF/FTC/EFV POR ABC/3TC/MVC | |||||||||||||
Medical condition: Virus de imunodeficiencia humana-1 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002319-13 | Sponsor Protocol Number: EfaRiLipidomics | Start Date*: 2015-08-28 | |||||||||||
Sponsor Name:Fundació Hospital Vall Hebron Institut de Recerca | |||||||||||||
Full Title: Outcome of plasma lipid profile in patients switching from Atripla® to Eviplera® compared to continuing on Atripla® (EfaRiLipidomics) | |||||||||||||
Medical condition: HIV-1 Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006716-30 | Sponsor Protocol Number: 128/2006/O/Sper | Start Date*: 2006-12-19 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Randomized, controlled, multicentric trial to evaluate efficacy and safety of the switch from a LPV/r based therapy to an ATV/r or a NVP based treatment in association with ABC/3TC, in HIV patient ... | |||||||||||||
Medical condition: HIV infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.